Scarica l'app Stockscreener
337.54
0.44%
1.47
Dopo l'orario di chiusura:
337.54
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$336.07
Aprire:
$334.87
Volume 24 ore:
4.13M
Relative Volume:
1.65
Capitalizzazione di mercato:
$181.76B
Reddito:
$35.89B
Utile/perdita netta:
$7.01B
Rapporto P/E:
26.09
EPS:
12.9352
Flusso di cassa netto:
$11.54B
1 W Prestazione:
+0.24%
1M Prestazione:
+12.09%
6M Prestazione:
+24.40%
1 anno Prestazione:
+16.43%
Intervallo 1D:
$334.74
$342.84
Intervallo di 1 settimana:
$334.74
$345.49
Portata 52W:
$253.30
$345.84
Amgen Inc Stock (AMGN) Company Profile
Nome
Amgen Inc
Settore
Industria
Telefono
(805)447-1000
Indirizzo
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Confronta AMGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
337.54 | 180.97B | 35.89B | 7.01B | 11.54B | 12.94 |
|
LLY
Lilly Eli Co
|
1,059.70 | 933.76B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
203.90 | 489.26B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
236.28 | 405.53B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
127.31 | 238.62B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
97.76 | 235.72B | 63.90B | 19.05B | 13.05B | 7.5596 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-09-03 | Ripresa | Raymond James | Mkt Perform |
| 2025-05-20 | Ripresa | Guggenheim | Neutral |
| 2025-04-22 | Ripresa | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Ripresa | BofA Securities | Underperform |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-14 | Iniziato | Citigroup | Neutral |
| 2024-10-17 | Iniziato | Bernstein | Outperform |
| 2024-10-14 | Downgrade | Truist | Buy → Hold |
| 2024-09-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Ripresa | Raymond James | Mkt Perform |
| 2024-02-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Hold |
| 2023-11-02 | Aggiornamento | Truist | Hold → Buy |
| 2023-10-20 | Ripresa | JP Morgan | Neutral |
| 2023-10-17 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Ripresa | BofA Securities | Neutral |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-04-24 | Reiterato | Oppenheimer | Outperform |
| 2023-03-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Reiterato | Truist | Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Underperform |
| 2022-10-31 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Iniziato | SVB Leerink | Mkt Perform |
| 2022-02-09 | Reiterato | Barclays | Equal Weight |
| 2022-02-09 | Reiterato | Jefferies | Buy |
| 2022-02-09 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Reiterato | Oppenheimer | Outperform |
| 2022-02-09 | Reiterato | Wells Fargo | Equal Weight |
| 2022-01-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-12-09 | Ripresa | Wells Fargo | Equal Weight |
| 2021-12-06 | Iniziato | Goldman | Buy |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-09-23 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Iniziato | Daiwa Securities | Buy |
| 2020-10-28 | Iniziato | UBS | Neutral |
| 2020-10-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Aggiornamento | Truist | Hold → Buy |
| 2020-10-09 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Downgrade | Truist | Buy → Hold |
| 2020-10-08 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Ripresa | Guggenheim | Neutral |
| 2020-03-31 | Iniziato | Wolfe Research | Peer Perform |
| 2020-03-30 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Iniziato | Barclays | Equal Weight |
| 2020-01-31 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-17 | Ripresa | Morgan Stanley | Overweight |
| 2019-11-12 | Iniziato | SunTrust | Buy |
| 2019-11-05 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-19 | Downgrade | Mizuho | Buy → Neutral |
| 2019-05-23 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Amgen Inc Borsa (AMGN) Ultime notizie
Rhumbline Advisers Reduces Holdings in Amgen Inc. $AMGN - MarketBeat
Mufg Securities Americas Inc. Increases Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stock Position Decreased by Neo Ivy Capital Management - MarketBeat
Amgen (NASDAQ:AMGN) SVP Nancy Grygiel Sells 3,139 Shares - MarketBeat
Amgen SVP Grygiel sells $1.05 million in AMGN stock By Investing.com - Investing.com Nigeria
Amgen Inc. $AMGN Shares Sold by Legal & General Group Plc - MarketBeat
Franklin Resources Inc. Sells 487,854 Shares of Amgen Inc. $AMGN - MarketBeat
Journey Strategic Wealth LLC Purchases 2,601 Shares of Amgen Inc. $AMGN - MarketBeat
Is Amgen Inc. stock a safe investment in uncertain marketsGap Up & Reliable Entry Point Trade Alerts - newser.com
MAI Capital Management Has $19.72 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Bought by Swiss National Bank - MarketBeat
Amgen Inc. $AMGN Shares Sold by Handelsbanken Fonder AB - MarketBeat
Prudential PLC Buys 12,743 Shares of Amgen Inc. $AMGN - MarketBeat
Why analysts raise outlook for Amgen Inc. (AMG0) stock2025 Momentum Check & High Accuracy Swing Trade Signals - newser.com
Ensign Peak Advisors Inc Sells 106,567 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by DNB Asset Management AS - MarketBeat
Brandywine Global Investment Management LLC Buys 312,480 Shares of Amgen Inc. $AMGN - MarketBeat
Oral Mucositis Market to Hit $2.84 Billion by 2032 | Amgen Inc, - openPR.com
Global markets live: Nvidia, Walmart, Google, Amgen, Target… - MarketScreener
Amgen (NASDAQ:AMGN) Given New $381.00 Price Target at HSBC - MarketBeat
FDA grants full approval for Amgen’s Imdelltra - The Pharma Letter
Amgen Inc. (NASDAQ:AMGN) Declares Quarterly Dividend of $2.38 - MarketBeat
Saturna Capital Corp Sells 67,043 Shares of Amgen Inc. $AMGN - MarketBeat
Seizert Capital Partners LLC Lowers Stock Position in Amgen Inc. $AMGN - MarketBeat
TD Waterhouse Canada Inc. Boosts Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Primecap Management Co. CA - MarketBeat
Renaissance Group LLC Purchases Shares of 105,962 Amgen Inc. $AMGN - MarketBeat
Pinnacle Wealth Planning Services Inc. Sells 755 Shares of Amgen Inc. $AMGN - MarketBeat
Is Amgen Inc. (NASDAQ:AMGN) A High Quality Stock To Own? - Yahoo Finance
Don't Ignore The Insider Selling In Amgen - simplywall.st
Amgen Inc. $AMGN Shares Purchased by Ade LLC - MarketBeat
Is Amgen Inc. (AMG0) stock a buy on weaknessJuly 2025 Sector Moves & Verified Swing Trading Watchlists - newser.com
What catalysts could drive Amgen Inc. stock higherJuly 2025 Pullbacks & Verified Momentum Stock Watchlist - newser.com
Is Amgen Inc. stock ready for a breakout2025 Top Gainers & Verified Momentum Stock Alerts - newser.com
Why Amgen Inc. (AMG) stock could rally strongly2025 Year in Review & Weekly Top Gainers Alerts - newser.com
Amgen (AMGN) Secures Full FDA Approval for Imdelltra in Lung Can - GuruFocus
Amgen's Imdelltra receives full FDA approval in small cell lung cancer - Seeking Alpha
Amgen Says FDA Granted Full Approval to Imdelltra to Treat Extensive Stage Small Cell Lung Cancer - MarketScreener
Amgen (AMGN) Secures Full FDA Approval for IMDELLTRA in Lung Can - GuruFocus
What dividend safety score for Amgen Inc. stockVolume Spike & Pattern Based Trade Signal System - newser.com
Fda grants full approval to Amgen's Imdelltra in extensive stage small cell lung cancer - MarketScreener
FDA GRANTS FULL APPROVAL TO AMGEN'S IMDELLTRA® IN EXTENSIVE STAGE SMALL CELL LUNG CANCER - PR Newswire
FDA Grants Full Approval to Amgen's (AMGN) Drug Imdelltra for Lu - GuruFocus
Alert incorrectly tagged to Amgen withdrawn - MarketScreener
Vitiligo Market Analysis and Forecasts 2025-2035 Featuring Abbvie, Incyte, Amgen, Pfizer, Clinuvel Pharmaceuticals, TWi Biotech, and Arcutis BiotherapeuticsResearchAndMarkets.com - The AI Journal
Hospital Care Collaboration and Licensing Agreements Analysis Report and Directory 2025: Upfront, Milestone, and Royalties for 726 Deals by Company A-Z, Therapy Focus and Technology Type - GlobeNewswire Inc.
Ex-Dividend Reminder: NextEra Energy, Amgen and CRH - Nasdaq
Amgen (NASDAQ:AMGN) Price Target Raised to $370.00 at Daiwa Capital Markets - MarketBeat
Vanguard Group Inc. Boosts Stake in Amgen Inc. $AMGN - MarketBeat
HSBC Adjusts Price Target on Amgen to $381 From $343, Maintains Buy Rating - MarketScreener
24,705 Shares in Amgen Inc. $AMGN Acquired by Nordwand Advisors LLC - MarketBeat
Amgen Inc Azioni (AMGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):